Keyphrases
Chronic Kidney Disease
89%
Fibroblast Growth Factor 23 (FGF23)
80%
Chronic Renal Insufficiency Cohort
76%
Heart Failure
27%
Confidence Interval
23%
Estimated Glomerular Filtration Rate
19%
Kidney Disease Progression
19%
Cardiac Function
17%
Multi-Ethnic Study of Atherosclerosis
17%
End-stage Kidney Disease
15%
Hazard Ratio
14%
Cardiovascular Risk
14%
Heart Failure with Preserved Ejection Fraction (HFpEF)
14%
Cardiovascular Disease
13%
Solute
12%
Atherosclerotic Cardiovascular Disease (ASCVD)
11%
Multivariable
11%
Heart Failure Hospitalization
11%
Phosphate
11%
Middle-aged Adults
10%
Incident Heart Failure
9%
Serum Phosphate
9%
Anemia
9%
Mineral Metabolism
9%
Cardiac Structure
9%
Iron Deficiency
9%
All-cause Mortality
8%
Ferric Citrate
8%
Kidney Clearance
8%
Hospitalization
7%
Retinopathy
7%
Risk Factors
7%
Hemoglobin
7%
Albumin-to-creatinine Ratio
7%
High Risk
7%
Cardiovascular Mortality
6%
Left Ventricular Mass
6%
Exercise Capacity
6%
United States
6%
Non-Hispanic White
6%
Microalbuminuria
6%
Solute Clearance
6%
Ejection Fraction
6%
Cardiovascular Outcomes
6%
Intact Parathyroid Hormone (iPTH)
6%
Albuminuria
6%
White People
6%
Adverse Outcomes
5%
Patients with Heart Failure
5%
Kidney Outcomes
5%
Medicine and Dentistry
Chronic Kidney Disease
100%
Cohort Analysis
64%
Fibroblast Growth Factor 23
57%
Cardiovascular Disease
21%
Cardiovascular System
19%
Congestive Heart Failure
19%
Glomerular Filtration Rate
18%
Atherosclerosis
17%
Kidney Function
12%
Hazard Ratio
12%
Renal Failure
9%
Heart Function
9%
Iron Deficiency
9%
Heart Failure with Preserved Ejection Fraction
8%
Ferric Citrate
8%
Retinopathy
8%
Renal Clearance
8%
Proportional Hazards Model
7%
All Cause Mortality
7%
Carboxy Terminal Sequence
7%
End Stage Renal Disease
7%
Mineral Metabolism
6%
Diabetes
6%
Nephropathy
6%
Biological Marker
6%
Exercise
6%
Cardiovascular Mortality
6%
Adverse Outcome
5%
Disease Exacerbation
5%
Renal Replacement Therapy
5%
Macroalbuminuria
5%
Microalbuminuria
5%
Ejection Fraction
5%
Metabolite
5%
Anemia
5%
Atrial Fibrillation
5%
Apoplexy
5%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
76%
Cohort Study
42%
Fibroblast Growth Factor 23
38%
Congestive Heart Failure
30%
Cardiovascular Disease
18%
Coronary Artery Atherosclerosis
11%
All Cause Mortality
10%
Heart Failure with Preserved Ejection Fraction
10%
End Stage Renal Disease
9%
Anemia
9%
Non Insulin Dependent Diabetes Mellitus
8%
Albuminuria
6%
Biological Marker
6%
Kidney Failure
5%
Kynurenic Acid
5%
Microalbuminuria
5%
Macroalbuminuria
5%
Prevalence
5%
Natriuretic Factor
5%
Disease
5%